|
|
|
Volumn 17, Issue 7 Suppl 7, 2003, Pages 30-40
|
|
The global role of irinotecan in the treatment of lung cancer: 2003 update.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CAMPTOTHECIN;
CISPLATIN;
DEOXYCYTIDINE;
DRUG DERIVATIVE;
ETOPOSIDE;
GEMCITABINE;
IRINOTECAN;
VINDESINE;
ADJUVANT CHEMOTHERAPY;
ADJUVANT THERAPY;
CANCER STAGING;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DRUG ADMINISTRATION;
HUMAN;
JAPAN;
LUNG TUMOR;
MULTICENTER STUDY;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SURVIVAL;
TREATMENT OUTCOME;
UNITED STATES;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CAMPTOTHECIN;
CHEMOTHERAPY, ADJUVANT;
CISPLATIN;
CLINICAL TRIALS, PHASE II;
CLINICAL TRIALS, PHASE III;
DEOXYCYTIDINE;
DRUG ADMINISTRATION SCHEDULE;
ETOPOSIDE;
HUMANS;
JAPAN;
LUNG NEOPLASMS;
MULTICENTER STUDIES;
NEOPLASM STAGING;
RADIOTHERAPY, ADJUVANT;
RANDOMIZED CONTROLLED TRIALS;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
UNITED STATES;
VINDESINE;
|
|
EID: 0142122111
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (19)
|
|
References (51)
|
